This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Astrazeneca Ab. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Per I Arvidsson: Innovator in Pharmaceutical Chemistry
Introduction
Per I Arvidsson is a notable inventor based in Södertälje, Sweden. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target critical health conditions.
Latest Patents
Arvidsson holds a patent for "Imidazole substituted pyrimidines." This patent encompasses imidazole substituted pyrimidines and pharmaceutically acceptable salts thereof. It also includes pharmaceutical formulations containing such pyrimidines and their therapeutic uses. Specifically, these compounds are aimed at treating conditions associated with glycogen synthase kinase-3 related disorders, such as Alzheimer's disease. The patent outlines methods of treatment involving the administration of therapeutically effective amounts of these compounds to subjects in need.
Career Highlights
Arvidsson is associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to focus on innovative solutions for complex medical challenges. His expertise in pharmaceutical formulations has contributed to advancements in therapeutic options for patients.
Collaborations
Throughout his career, Arvidsson has collaborated with talented professionals, including Jeremy Nicholas Burrows and Erica Tjerneld. These collaborations have fostered a productive environment for innovation and research.
Conclusion
Per I Arvidsson's contributions to pharmaceutical chemistry, particularly through his patent on imidazole substituted pyrimidines, highlight his role as an innovator in the field. His work continues to impact the development of therapies for serious health conditions.